Knowledge and perceptions about generic drugs by users of PSF in triple borders

Cicchelero, Laiz Mangini; Toninato, Ana Paula Contiero; Silva, Rosane Meire Munhak da; Faller, Jossiana Wilke; Rossoni, Diogo Francisco; Domareski, Jackson Luiz; Silva-Sobrinho, Reinaldo Antônio; Zilly, Adriana.
Cad. saúde colet., (Rio J.) ; 28(2): 260-270, abr.-jun. 2020. tab
Artigo em Inglês | LILACS-Express | ID: biblio-1132954

Documentos relacionados

  1. Generic Medicinal Products in Immunosuppressive Therapy-Should It be a Challenge for Therapeutic Drug Monitoring?
  2. Quality Control Study of Different Products from Famotidine Tablets in the Iraqi Market
  3. Avaliação das dificuldades enfrentadas pelo paciente para realização de uma consulta médica de nível terciário
  4. Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data.
  5. The impact of the legal regime of intellectual property protection in the pharmaceutical market.
  6. The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: differences and commonalities.
  7. Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems.
  8. Review: Role of Model-Informed Drug Development Approaches in the Lifecycle of Drug Development and Regulatory Decision-Making.
  9. Linguistic Analysis of Generic-Generic Drug Name Pairs Prone to Wrong-Drug Errors for which Tall-Man Lettering is Recommended.
  10. Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.